These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30766428)

  • 1. Utilizing mixer torque rheometer in the prediction of optimal wet massing parameters for pellet formulation by extrusion/spheronization.
    Ibrahim MA; Zayed GM; Alsharif FM; Abdelhafez WA
    Saudi Pharm J; 2019 Feb; 27(2):182-190. PubMed ID: 30766428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations.
    Barbosa EJ; Ferraz HG
    Acta Pharm; 2019 Mar; 69(1):99-109. PubMed ID: 31259713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization.
    Ibrahim MA; Alshora DH
    Polymers (Basel); 2021 Nov; 13(22):. PubMed ID: 34833333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration.
    Garekani HA; Nokhodchi A; Rayeni MA; Sadeghi F
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1238-46. PubMed ID: 22873946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting optimal wet granulation parameters for extrusion-spheronisation of pharmaceutical pellets using a mixer torque rheometer.
    Kuhs M; Moore J; Kollamaram G; Walker G; Croker D
    Int J Pharm; 2017 Jan; 517(1-2):19-24. PubMed ID: 27915006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and evaluation of Lisinopril mucoadhesive sustained release matrix pellets:
    Alagili MF; AlQuadeib BT; Ashri LY; Ibrahim MA
    Saudi Pharm J; 2023 Aug; 31(8):101690. PubMed ID: 37457369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.
    Saripella KK; Loka NC; Mallipeddi R; Rane AM; Neau SH
    AAPS PharmSciTech; 2016 Apr; 17(2):368-79. PubMed ID: 26169900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of effect of excipient source variation on rheological behavior of diltiazem HCl-HPMC wet masses using a mixer torque rheometer.
    Chatlapalli R; Rohera BD
    Int J Pharm; 2002 May; 238(1-2):139-51. PubMed ID: 11996818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrusion-Spheronization of blends of carbopol 934 and microcrystalline cellulose.
    Gómez-Carracedo A; Alvarez-Lorenzo C; Gómez-Amoza JL; Martínez-Pacheco R; Souto C; Concheiro A
    Drug Dev Ind Pharm; 2001 May; 27(5):381-91. PubMed ID: 11448045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wetting agent dosage screening for traditional Chinese medicine pellet based on torque rheological property].
    Li X; Hong YL; Xian JC; Feng Y; Zheng YP; Chu SC
    Zhongguo Zhong Yao Za Zhi; 2017 Sep; 42(17):3341-3349. PubMed ID: 29192444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of diclofenac sodium sustained release matrix pellets: impact of polyethylene glycols molecular weight.
    Ibrahim A; Shazly A
    Acta Pol Pharm; 2014; 71(5):821-31. PubMed ID: 25362811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
    Sarkar S; Heng PW; Liew CV
    Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.